Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.23.3
Consolidated Balance Sheets - USD ($)
$ in Thousands
Jul. 31, 2023
Jul. 31, 2022
Current assets:    
Cash and cash equivalents $ 82,373 $ 21,603
Accounts receivable, net 4,808 4,762
Inventories, net 7,939 9,516
Prepaid expenses and other current assets, including $1,000 restricted cash 3,336 2,816
Current assets of discontinued operations, net 4,126
Total current assets 98,456 42,823
Property, plant, and equipment, net 13,086 11,636
Right-of-use assets 3,626 4,384
Other assets, including $5,000 escrow at July 31, 2023 5,745 1,309
Non-current assets of discontinued operations, net 967 15,459
Total assets 121,880 75,611
Current liabilities:    
Accounts payable – trade 3,575 3,715
Accrued liabilities 11,743 8,179
Current portion of operating lease liabilities 980 896
Other current liabilities 75 229
Convertible debentures 2,514
Current liabilities of discontinued operations, net 21,102
Total current liabilities 39,989 13,019
Operating lease liabilities, non-current 3,160 4,053
Long term debt, net 269 4,077
Total liabilities 43,418 21,149
Commitments and contingencies – see Notes 16 and 17
Stockholders’ equity:    
Preferred Stock, $.01 par value; authorized 25,000,000 shares; no shares issued or outstanding
Common Stock, $.01 par value; authorized 75,000,000 shares; shares issued and outstanding: 49,997,631 at July 31, 2023 and 48,720,454 at July 31, 2022 499 487
Additional paid-in capital 344,435 339,462
Accumulated deficit (268,350) (288,638)
Accumulated other comprehensive income 1,878 3,151
Total stockholders’ equity 78,462 54,462
Total liabilities and stockholders’ equity $ 121,880 $ 75,611